Skip to main content

Table 1 Characteristics of included guidelines

From: Quality assessment of the guidelines for the management of malignant pleural effusions and ascites

Guideline ID

Organization

Country/area

Version

Topic

Grading system

Method

ATS, 2018 [5]

ATS/STS/STR

America

Original

Management of malignant pleural effusions

GRADE

EB

ERS, 2018 [2]

ERS/EACTS

Europe

Original

Management of malignant pleural effusions

Unclear

EB

BTS, 2010 [3]

BTS

Britain

Original

Management of malignant pleural effusions

Unclear

EB

CGDTMPE, 2014 [4]

CGDTMPE

China

Original

Malignant pleural effusions

Unclear

CB

CSCO, 2018 [1]

CSCO

China

Original

Administration of rmhTNF for malignant ascites

Unclear

EB

CTS, 2009 [6]

CTS

China

Original

Respiratory diseases

Unclear

CB

JSPM1, 2016 [7]

JSPM

Japan

Original

Parenteral fluid management for terminal cancer patients

GRADE

CB

JSPM2, 2016 [8]

JSPM

Japan

Original

Treatment recommendations for respiratory symptoms in cancer patients

GRADE

EB

JSPM, 2019 [9]

JSPM

Japan

Original

Gastrointestinal symptoms in cancer patients

GRADE

EB

  1. ATS American Thoracic Society, STS Society of Thoracic Surgeons, STR Society of Thoracic Radiology, ERS European Respiratory Society, EACTS European Association for Cardio-Thoracic Surgery, BTS British Thoracic Society, JSPM Japanese Society for Palliative Medicine, CSCO Chinese Society of Clinical Oncology, CGDTMPE Chinese Expert Consensus Group on Diagnosis and Treatment of Malignant Pleural Effusion, CTS Chinese Thoracic Society, CB Consensus based, EB Evidence based